Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Rekombinanter Cytokeratin 7 Antikörper

KRT7 Reaktivität: Human WB, IHC, FACS, StM Wirt: Maus Monoclonal rOV-TL12-30 unconjugated Recombinant Antibody
Produktnummer ABIN6939869
  • Target Alle Cytokeratin 7 (KRT7) Antikörper anzeigen
    Cytokeratin 7 (KRT7) (Keratin 7 (KRT7))
    Antikörpertyp
    Recombinant Antibody
    Reaktivität
    • 204
    • 71
    • 61
    • 7
    • 6
    • 5
    • 3
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    Human
    Wirt
    • 123
    • 89
    • 1
    Maus
    Klonalität
    • 114
    • 98
    • 1
    Monoklonal
    Konjugat
    • 86
    • 20
    • 15
    • 6
    • 6
    • 6
    • 6
    • 6
    • 6
    • 5
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    Dieser Cytokeratin 7 Antikörper ist unkonjugiert
    Applikation
    • 125
    • 85
    • 84
    • 82
    • 41
    • 28
    • 28
    • 26
    • 24
    • 22
    • 19
    • 15
    • 5
    • 4
    • 3
    • 2
    • 1
    • 1
    • 1
    Western Blotting (WB), Immunohistochemistry (IHC), Flow Cytometry (FACS), Staining Methods (StM)
    Spezifität
    It recognizes an intermediate filament protein (IFP) of 55 kDa, which is identified as cytokeratin 7. This MAb is highly specific to cytokeratin 7 and shows no cross-reaction with other IFPs. Cytokeratin 7 is a basic cytokeratin, which is found in most glandular and transitional epithelia but not in the stratified squamous epithelia. Keratin 7 is expressed in the epithelial cells of ovary, lung, and breast but not of colon, prostate, or gastrointestinal tract. This MAb is highly useful in distinguishing ovarian carcinomas (keratin 7+) from colon carcinomas (keratin 7-).
    Aufreinigung
    Purified by Protein A/G
    Immunogen
    Recombinant full-length human KRT7 protein
    Klon
    ROV-TL12-30
    Isotyp
    IgG1 kappa
    Top Product
    Discover our top product KRT7 Primärantikörper
  • Applikationshinweise

    Positive Control: HeLa cells. Carcinoma of ovary, lung, cervix or breast.

    Known Application: Western Blot (1-2 μg/mL), Flow Cytometry (1-2 μg/million cells), Immunohistochemistry (Formalin-fixed) (0.5-1.0 μg/mL for 30 minutes at RT)(Staining of formalin-fixed tissues requires boiling tissue sections in 10 mM Citrate Buffer, pH 6.0, for 10-20 min followed by cooling at RT for 20 minutes)Optimal dilution for a specific application should be determined.

    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Konzentration
    200 μg/mL
    Buffer
    10 mM PBS with 0.05 % BSA & 0.05 % azide.
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    4 °C,-80 °C
    Informationen zur Lagerung
    Antibody with azide - store at 2 to 8°C. Antibody without azide - store at -20 to -80°C. Antibody is stable for 24 months. Non-hazardous. No MSDS required.
    Haltbarkeit
    24 months
  • Target
    Cytokeratin 7 (KRT7) (Keratin 7 (KRT7))
    Andere Bezeichnung
    KRT7 (KRT7 Produkte)
    Synonyme
    CK7 antikoerper, K2C7 antikoerper, K7 antikoerper, SCL antikoerper, D15Wsu77e antikoerper, Krt2-7 antikoerper, KRT7 antikoerper, keratin 7 antikoerper, KRT7 antikoerper, Krt7 antikoerper
    Molekulargewicht
    55kDa
    Gen-ID
    3855
    UniProt
    P08729
Sie sind hier:
Kundenservice